Results
Eris Lifesciences FY26 Revenue Hits ₹3,129 Crore with 76% Profit Growth
Eris Lifesciences reported consolidated revenue of ₹3,129 crore with 8% YoY growth and 76% net profit increase to ₹619.5 crore for FY 2025-26.
The company strengthened its insulin franchise with marke
